Hazard Information | Back Directory | [Biological Activity]
Sutimlimab, a first-in-class humanized immunoglobulin G4 (IgG4) monoclonal antibody that selectively inhibits the classical complement pathway at C1s, rapidly halted hemolysis in the single-arm CARDINAL study in recently transfused patients with cold agglutinin disease (CAD). |
|
Company Name: |
Biolab Reagents
|
Tel: |
027-65279366 18108604862 |
Website: |
www.biolabreagent.com/ |
|